4.6 Article

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells

期刊

BMC CANCER
卷 18, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/s12885-018-4233-9

关键词

Melanoma; Cisplatin; miR-30a-5p; IGF1R; Chemo-resistance

类别

资金

  1. Natural Science Foundation of Guangdong Province [2015A030313754]
  2. Sanming Project of Shenzhen [SZSM201612061, SZSM201612041]
  3. Shenzhen Science and Technology Plan of Basic Research Projects [JCYJ20140416144209741, JCYJ20150403091443300, JCYJ20160427185121156, JCYJ20170306161757367]

向作者/读者索取更多资源

Background: Melanoma is notoriously resistant to all current modalities of cancer therapies including chemotherapy. In recent years, microRNAs (miRNAs) have emerged as molecular regulators in the development and progression of melanoma. However, the relationship between microRNA and chemo-resistance of melanoma is little known. In present study, we aimed to investigate the miRNAs related to cisplatin-resistance in melanoma cells. Methods: After cisplatin (DDP) resistant melanoma cells (M8/DDP and SK-Mel-19/DDP) were established in-vitro, high-throughput screening of differentially expressed miRNAs between resistant cells and parental cells were performed. Results: It was found that a cancer-related miRNA, miR-30a-5p, was highly over-expressed in resistant cells. Transfection of miR-30a-5p mimic or inhibitor could alter the sensitivity of melanoma cells to cisplatin. Next, we showed that Insulin Like Growth Factor 1 Receptor (IGF1R) gene turned out to be a direct target of miR-30a-5p. Knockdown of IGF1R in melanoma cells could not only reduce the sensitivity to cisplatin but also lead to cell cycle arrest by regulating phosphorylation of Serine-Threonine Protein Kinase (P-AKT (Ser473)) and Tumor Protein P53 (P53). Conclusion: Taken together, our study demonstrated that miR-30a-5p could influence chemo-resistance by targeting IGF1R gene in melanoma cells, which might provide a potential target for the therapy of chemo-resistant melanoma cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据